SARS-CoV-2 (COVID-19) Envelope Peptide
| Code | Size | Price |
|---|
| PSI-9169P-0.05mg | 0.05mg | £166.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Target Species: Virus
Application: Blocking
Storage:
Store SARS-CoV-2 (COVID-19) Envelope Peptide at -20˚C, stable for one year.
Documents
Further Information
Additional Names:
SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Envelope protein, E protein
Application Note:
SARS-CoV-2 (COVID-19) Envelope Peptide is used for blocking the activity of the SARS-CoV-2 (COVID-19) Envelope Antibody.
Background References:
- Gorbalenya. bioRxiv: 2020.
- Hui et al. Int J Infect Dis. 2020;91:264-266.
- Pervushin et al. PLoS Pathog. 2009; 5(7): e1000511.
Buffer:
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Concentration:
200 ug/mL
NCBI Gene ID #:
43740570
NCBI Official Name:
envelope protein
NCBI Official Symbol:
E
NCBI Organism:
SARS-CoV-2 coronavirus
Peptide aa Location:
14 amino acids near the carboxyl terminus of SARS-CoV-2 (COVID-19) Envelope protein.
Physical State:
Liquid
Protein Accession #:
QHD43418
Protein GI Number:
1791269092
Swissprot #:
QHD43418